SHLT

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.51
Percentage change -14.91	%

Peers: TDOC AMWL GDRX DOCS CLOV HIMS AMRX HQY RCM OSCR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.54	Insider Own	-	Shs Outstand	10.49M	Perf Week	7.78%
Market Cap	47.69M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-4.00%
Income	-8.87M	PEG	-	EPS next Q	-	Inst Own	16.74%	Short Float	-	Perf Quarter	-16.86%
Sales	56.16M	P/S	0.85	EPS this Y	-	Inst Trans	0.02%	Short Ratio	0.15	Perf Half Y	-50.00%
Book/sh	4.11	P/B	0.71	EPS next Y	-	ROA	-7.97%	Short Interest	0.00M	Perf Year	-71.75%
Cash/sh	1.24	P/C	2.35	EPS next 5Y	-	ROE	-12.35%	52W Range	2.54 - 9.30	Perf YTD	-63.51%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.96%	52W High	-68.71%	Beta	-0.48
Dividend TTM	-	Quick Ratio	1.98	Sales past 5Y	4.10%	Gross Margin	45.73%	52W Low	14.57%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	2.17	EPS Y/Y TTM	-272.10%	Oper. Margin	-11.43%	RSI (14)	50.87	Volatility	7.68% 4.95%
Employees	583	Debt/Eq	0.27	Sales Y/Y TTM	-0.88%	Profit Margin	-15.80%	Recom	1.00	Target Price	11.00
Option/Short	No / No	LT Debt/Eq	0.20	EPS Q/Q	-	Payout	-	Rel Volume	10.33	Prev Close	3.42
Sales Surprise	1.96%	EPS Surprise	-42.11%	Sales Q/Q	-	Earnings	Sep 26 BMO	Avg Volume	18.60K	Price	2.91
SMA20	3.09%	SMA50	0.70%	SMA200	-41.61%	Trades		Volume	61,597	Change	-14.91%

Jul-29-24 04:30AM	SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine (Business Wire)
Jun-20-24 06:32AM	SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity (Business Wire)
May-21-24 01:45AM	SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test (Business Wire)
May-16-24 01:45AM	SHL Telemedicine Announces Official Launch of SmartHeart D2C Membership in the US Following Successful Soft Launch (Business Wire) +10.02%
Apr-17-24 05:00AM	SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones (Business Wire)
02:10AM	Loading…
Apr-11-24 02:10AM	Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicines SmartHeart in Post-ACS Patient Care (Business Wire)
Apr-08-24 02:30AM	SHL Telemedicines SmartHeart Technology Triumphs in US Army Project Convergence Capstone 4 Experiment (Business Wire)
Apr-05-24 02:30AM	SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023 (Business Wire) -8.47%
Mar-14-24 10:40AM	SHL Telemedicine Receives Buy Rating with $11.00 Price Target (Business Wire)
Feb-01-24 02:30AM	Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicines SmartHeart Technology, to Be Presented at ACC 24 (Business Wire) +6.41%
Dec-19-23 02:36AM	SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024 (Business Wire)
Nov-27-23 02:00AM	SHL Telemedicine Introduces SmartHeart Direct-to-Consumer Membership Plan in the US (Business Wire)
Nov-06-23 01:48AM	SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits (Business Wire)
Oct-23-23 01:00AM	SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US (Business Wire)
Sep-26-23 02:43AM	SHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials (Business Wire)
07:54AM	Loading…
Sep-21-23 07:54AM	SHL Announces Half-Year Results 2023 Strategic Moves to Accelerate Growth (Business Wire)
Sep-11-23 01:34AM	SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference (Business Wire)
Sep-06-23 08:00AM	SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023 (PR Newswire)

SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SHL Telemedicine Ltd. ADR

Upgrade your FINVIZ experience